home / stock / acxp / acxp quote
Last: | $2.08 |
---|---|
Change Percent: | -3.23% |
Open: | $2.24 |
Close: | $2.08 |
High: | $2.24 |
Low: | $2.0449 |
Volume: | 41,098 |
Last Trade Date Time: | 05/06/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.08 | $2.24 | $2.08 | $2.24 | $2.0449 | 41,098 | 05-06-2024 |
$2.17 | $2.2 | $2.17 | $2.2059 | $2.1 | 32,860 | 05-03-2024 |
$2.12 | $2.15 | $2.12 | $2.22 | $2.06 | 25,535 | 05-02-2024 |
$2.16 | $2.21 | $2.16 | $2.32 | $2.13 | 78,610 | 05-01-2024 |
$2.2 | $2.13 | $2.2 | $2.33 | $2.1018 | 36,147 | 04-30-2024 |
$2.19 | $2.05 | $2.19 | $2.33 | $2.02 | 85,897 | 04-29-2024 |
$2.07 | $2.04 | $2.07 | $2.08 | $1.98 | 28,608 | 04-26-2024 |
$2.02 | $2.03 | $2.02 | $2.13 | $1.96 | 85,176 | 04-25-2024 |
$2.03 | $2.07 | $2.03 | $2.07 | $1.9657 | 16,633 | 04-24-2024 |
$2.04 | $1.96 | $2.04 | $2.05 | $1.94 | 29,691 | 04-23-2024 |
$1.98 | $1.99 | $1.98 | $2.01 | $1.9 | 52,022 | 04-22-2024 |
$2.01 | $2.08 | $2.01 | $2.17 | $1.95 | 94,606 | 04-19-2024 |
$2.13 | $1.9 | $2.13 | $2.13 | $1.8 | 144,168 | 04-18-2024 |
$1.8 | $1.66 | $1.8 | $1.8425 | $1.62 | 117,397 | 04-17-2024 |
$1.66 | $1.74 | $1.66 | $1.7899 | $1.52 | 247,497 | 04-16-2024 |
$1.635 | $1.8 | $1.635 | $1.85 | $1.62 | 94,678 | 04-15-2024 |
$1.77 | $1.86 | $1.77 | $1.86 | $1.6601 | 172,233 | 04-12-2024 |
$1.87 | $1.84 | $1.87 | $1.91 | $1.84 | 25,444 | 04-11-2024 |
$1.86 | $1.89 | $1.86 | $1.9599 | $1.8 | 122,247 | 04-10-2024 |
$1.93 | $1.94 | $1.93 | $1.952 | $1.8901 | 24,775 | 04-09-2024 |
News, Short Squeeze, Breakout and More Instantly...
Acurx Pharmaceuticals Inc. Company Name:
ACXP Stock Symbol:
NASDAQ Market:
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference PR Newswire STATEN ISLAND, N.Y. , May 2, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Compa...
Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference PR Newswire STATEN ISLAND, N.Y. , April 25, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the...
Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , April 23, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Co...